Bixiye
bc-com-pharmprogpolicynotifctn-eff-7-15-24.pdf
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 811 - 820 ee natiijooyinka 3563
Bixiye
QP44-24 MHCP Pharmacy Benefit Exclusion for Anktiva® and Docivyx™
Taariikhda uu dhaqangalayo Barnaamijka: May 22, 2024
Bixiye
QP38-24 Training Webinars for New Prior Authorization Submission Process
Taariikhda uu dhaqangalayo Barnaamijka: May 22, 2024
Bixiye
QP37-24 Update for New-to-Market Medical Drugs: atidarsagene autotemcel, crovalimab, and fidanacogene eleparvovec
Taariikhda uu dhaqangalayo Barnaamijka: May 08, 2024
Bixiye
QP43-24 MHCP Pharmacy Benefit Exclusion for Alyglo™ and Lenmeldy™
Taariikhda uu dhaqangalayo Barnaamijka: May 08, 2024
Bixiye
QP42-24 Commercial Pharmacy Benefit Exclusion for Lenmeldy™
Taariikhda uu dhaqangalayo Barnaamijka: May 08, 2024